当前位置：
X-MOL 学术
›
Eur. Gastroenterol. Hepatol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Impact of MAFLD criteria on postoperative recurrence of non-B, non-C HCC.
European Journal of Gastroenterology & Hepatology ( IF 2.1 ) Pub Date : 2024-02-23 , DOI: 10.1097/meg.0000000000002720 Yusuke Johira 1 , Takashi Nakahara 1 , Kenji Yamaoka 1 , Yasutoshi Fujii 1 , Shinsuke Uchikawa 1 , Hatsue Fujino 1 , Atsushi Ono 1 , Eisuke Murakami 1 , Tomokazu Kawaoka 1 , Daiki Miki 1 , Masataka Tsuge 1 , Shiro Oka 1
European Journal of Gastroenterology & Hepatology ( IF 2.1 ) Pub Date : 2024-02-23 , DOI: 10.1097/meg.0000000000002720 Yusuke Johira 1 , Takashi Nakahara 1 , Kenji Yamaoka 1 , Yasutoshi Fujii 1 , Shinsuke Uchikawa 1 , Hatsue Fujino 1 , Atsushi Ono 1 , Eisuke Murakami 1 , Tomokazu Kawaoka 1 , Daiki Miki 1 , Masataka Tsuge 1 , Shiro Oka 1
Affiliation
This study aimed to clarify the population in whom the presence of metabolic dysfunction-associated fatty liver disease (MAFLD) especially contributes to recurrence after liver resection for non-B, non-C hepatocellular carcinoma (NBNC-HCC).
中文翻译：
MAFLD 标准对非 B、非 C HCC 术后复发的影响。
本研究旨在明确代谢功能障碍相关脂肪肝病 (MAFLD) 的存在尤其会导致非 B、非 C 型肝细胞癌 (NBNC-HCC) 肝切除术后复发的人群。
更新日期：2024-02-23
中文翻译：
MAFLD 标准对非 B、非 C HCC 术后复发的影响。
本研究旨在明确代谢功能障碍相关脂肪肝病 (MAFLD) 的存在尤其会导致非 B、非 C 型肝细胞癌 (NBNC-HCC) 肝切除术后复发的人群。
京公网安备 11010802027423号